SCHEMBL18735236

SCHEMBL18735236

CCC(=O)NC(C(=O)N(CC)CC)C(C)(C)SC(=O)CC(=O)SC(C)(C)C(NC(C)=O)C(=O)N(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18737710 0.87 CYP2C9 (0.32) —
SCHEMBL18735153 0.85 — —
SCHEMBL18735195 0.83 GAA (0.34) —
SCHEMBL18735235 0.83 CYP2C9 (0.33) —
SCHEMBL18735143 0.82 LMNA (0.31) —
SCHEMBL18735413 0.81 CA1 (0.32) —
SCHEMBL18734937 0.80 — —
SCHEMBL24144161 0.77 — —
SCHEMBL18734964 0.75 — —
SCHEMBL18734970 0.74 MGAM (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback